Suzhou Otovia Therapeutics Co., Ltd.
PrivateLast Round
VC Round
Jan 4, 2026
Company Overview
Suzhou Otovia Therapeutics Co., Ltd. is a biotechnology company that develops AAV-based gene therapies for the treatment of hearing loss and related neurodegenerative conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Suzhou Otovia Therapeutics Co., Ltd. Comparables
Compare Suzhou Otovia Therapeutics Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Skylark Bio | 86% | |
| Shanghai Refreshgene Technology Co., Ltd. | 81% | |
| Eli Lilly and Company | 79% | |
Suzhou Otovia Therapeutics Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 4, 2026 | ||||
| Angel | Jan 1, 2022 |
Suzhou Otovia Therapeutics Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dingxin Capital | VC Round |
| 南京市创新投资集团有限责任公司 | VC Round |
Suzhou Otovia Therapeutics Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Suzhou Otovia Therapeutics Co., Ltd.'s valuation, stock price, and market status.